|
Market Closed -
Nasdaq
21:00:00 21/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 2.090 USD | -0.48% |
|
+1.95% | +52.55% |
| 08-13 | Allogene Therapeutics Remains Attractive Given Valuation, Clinical Strategy, RBC Says | MT |
| 08-13 | Allogene Therapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 |
| Market Cap | 722M 619M 579M 530M 994M 69.09B 1.01B 6.84B 2.67B 34.71B 2.71B 2.65B 115B | P/E 2026 * |
-3.46x | P/E 2027 * | -3.26x |
|---|---|---|---|---|---|
| Enterprise Value | 526M 450M 421M 386M 724M 50.28B 733M 4.98B 1.94B 25.26B 1.97B 1.93B 83.55B | EV / Sales 2026 * |
155x | EV / Sales 2027 * | 47.3x |
| Free-Float |
83.55% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Allogene Therapeutics, Inc.
| 1 day | -0.48% | ||
| 1 week | +1.95% | ||
| Current month | +11.17% | ||
| 1 month | +12.97% | ||
| 3 months | +6.63% | ||
| 6 months | +1.95% | ||
| Current year | +52.55% |
| 1 week | 2 |  | 2.23 |
| 1 month | 1.61 | | 2.23 |
| Current year | 1.31 | | 4.46 |
| 1 year | 1.04 | | 4.46 |
| 3 years | 0.86 | | 5.78 |
| 5 years | 0.86 | | 27.86 |
| 10 years | 0.86 | | 55 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zachary Roberts
CEO | Chief Executive Officer | 48 | 30/06/2026 |
Geoffrey Parker
DFI | Director of Finance/CFO | 61 | 15/10/2023 |
Benjamin Beneski
CTO | Chief Tech/Sci/R&D Officer | 49 | 27/02/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Arie Belldegrun
CHM | Chairman | 76 | 31/10/2017 |
David Chang
BRD | Director/Board Member | 66 | 31/05/2018 |
Joshua Kazam
BRD | Director/Board Member | 49 | 31/10/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01/07/26 | Free | Chief Executive Officer | 610,720 | 0.1769% | ||
| 18/06/26 | Free | Director | 95,400 | 0.0276% | ||
| 18/06/26 | Free | Director | 95,400 | 0.0276% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.48% | +1.95% | +86.61% | -46.41% | 722M | |
| -3.00% | +2.27% | +77.60% | +109.33% | 72.12B | |
| +1.90% | +23.53% | +56.60% | +97.76% | 65.85B | |
| +5.12% | +25.22% | +5.24% | -0.82% | 29.28B | |
| +0.55% | +1.64% | -5.15% | +471.68% | 27.47B | |
| +2.74% | +12.98% | +62.84% | +28.14% | 26.7B | |
| +0.47% | +6.12% | +36.66% | -13.79% | 20.06B | |
| +1.82% | -6.67% | +247.46% | +393.10% | 18.22B | |
| +0.94% | +3.36% | +18.55% | +532.94% | 16.4B | |
| +0.73% | +5.54% | +39.71% | +153.07% | 13.4B | |
| Average | +1.08% | +7.72% | +62.61% | +172.50% | 29.02B | |
| Weighted average by Cap. | +0.74% | +9.46% | +59.11% | +157.30% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.4M 2.91M 2.73M 2.49M 4.68M 325M 4.74M 32.2M 12.56M 163M 12.77M 12.49M 541M | 12.09M 10.35M 9.69M 8.87M 16.64M 1.16B 16.86M 114M 44.63M 581M 45.38M 44.39M 1.92B |
| Net income | -185M -159M -148M -136M -255M -17.71B -258M -1.75B -684M -8.9B -695M -680M -29.43B | -220M -188M -176M -161M -303M -21.03B -307M -2.08B -812M -10.57B -825M -808M -34.95B |
| Net Debt | -197M -168M -158M -144M -271M -18.8B -274M -1.86B -726M -9.45B -738M -722M -31.24B | -150M -129M -120M -110M -207M -14.37B -210M -1.42B -555M -7.22B -564M -552M -23.87B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/08/26 | US$2.090 | -0.48% | 4,372,792 |
| 20/08/26 | US$2.100 | -5.83% | 4,861,236 |
| 19/08/26 | US$2.230 | +9.85% | 6,714,917 |
| 18/08/26 | US$2.030 | -2.40% | 4,088,803 |
| 17/08/26 | US$2.080 | +1.46% | 4,676,700 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ALLO Stock
Select your edition
All financial news and data tailored to specific country editions
